In our experiments, despite an irregular change in total MOG-specific CD8 + T cells in MS patients, MOG-specific CD8 + T CM and CD8 + T EM exhibited a decreasing trend at 14 and 28 d post-treatment with teriflunomide, a well-known immunosuppressant agent ( 30 ).
← all excerpts
Characterization of antigen-specific CD8+ memory T cell subsets in peripheral blood of patients with multiple sclerosis.
2
—
—
The sentences
OND patients demonstrated slightly higher expression of Tim-3 on MOG-specific CD8 + T EM and CD8 + T CM than HC, but did not reach statistical significance ( Figures 3E, J ).